Trulieve Cannabis (TRLV) Cash & Current Investments (2020 - 2026)

Trulieve Cannabis has reported Cash & Current Investments for 7 years, with the latest figure at $325.4 million in Q2 2026.

• On a quarterly basis, Cash & Current Investments fell 17.11% year-over-year to $325.4 million in Q2 2026; TTM through Jun 2026 was $325.4 million, a 17.11% decrease from a year earlier, with the FY2025 full-year figure at $255.5 million, down 14.59% from the prior year.
• Cash & Current Investments was $325.4 million for Q2 2026 at Trulieve Cannabis, down from $352.9 million in the prior quarter.
• The five-year high for Cash & Current Investments was $450.1 million in Q3 2025, with the low at $100.7 million in Q3 2022.
• Average Cash & Current Investments over 5 years is $266.5 million, with a median of $261.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Cash & Current Investments plunged 52.87% in 2022, then soared 133.11% in 2024.
• Over 5 years, Cash & Current Investments stood at $207.2 million in 2022, then increased by 0.38% to $208.0 million in 2023, then jumped by 43.86% to $299.2 million in 2024, then declined by 14.59% to $255.5 million in 2025, then increased by 27.35% to $325.4 million in 2026.
• The last three Cash & Current Investments figures came in at $325.4 million (Q2 2026), $352.9 million (Q1 2026), and $255.5 million (Q4 2025), per Business Quant data.